TEGO® Carbomer 140 G is being introduced by the product line Personal Care of Evonik for the first time in North America at the New York Society of Cosmetic Chemists Suppliers’ Day (Booth 204).
Carbomers are widely used as rheology modifiers and suspending agents in the personal care industry. They stabilize and thicken formulations like gels, emulsions or surfactant based applications. The standard Carbomer types are available as powders.
TEGO® Carbomer 140 G is an excellent viscosity adjuster, viscosity builder and emulsion stabilizer. It is the first Carbomer on the market that is based on n-heptane and ethyl acetate, which are class 3 solvents according to Pharmacopoe Européenne and to USP. The new product is especially suitable for cosmetic or pharmaceutical emulsions and gels.
“The granulated quality of TEGO® Carbomer 140 G offers numerous advantages compared to standard powder types.” states Dr. Sascha Herrwerth, Technical Manager, Rinse-off. “It causes low dusting and offers a high flow ability. The bulk density is 3.5 times higher compared to powder types, which leads to a reduced shipping volume.”
The performance of TEGO® Carbomer 140 G is comparable with conventional powder type products, but it is easier to disperse and easier to handle. TEGO® Carbomer 140 G is soluble in both water and alcohol and can be used over a wide pH range. It is very quickly dispersed in water without the formation of lumps. It is especially suitable for the preparation of clear water or alcohol-based gels, for the preparation and stabilization of creams, lotions and suspensions and is also recommended for the manufacturing of high viscous emulsions.
Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2008 about 41,000 employees generated sales of about €15.9 billion and an operating profit EBITDA of about €2.2 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.